Cancer Drug

Diplomat Receives Limited Distribution Contract For Cancer DrugDiplomat, the country’s largest independent specialty pharmacy, announced it is one of five specialty pharmacies selected as a provider of Imbruvica (ibrutinib) capsules, approved Nov. 13 by the U.S. Food and Drug Administration for the treatment of mantle cell lymphoma.
Ann Arbor Startup Starts Human Trial Of Adrenal Cancer DrugA startup biotech company has started a Phase 1 human clinical trial of a drug to treat a rare form of cancer.
ProNAi Presents Cancer Drug Results, Expands Management TeamProNAi Therapeutics Inc., a cancer drug development company, said last week that it had concluded its initial human clinical trial of PNT2258, a new type of nucleic acid drug.
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen